Clinical Trial Update: A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children [Phase 3]

View source ↗

Summary

Pfizer carried out a Phase 3 safety study of voriconazole in children with invasive aspergillosis and other rare molds; the trial was terminated and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis

Drugs mentioned

• Vfend (voriconazole) (voriconazole)

Snippet

Sponsor: Pfizer | Conditions: Invasive Aspergillosis | Phase 3 | Status: TERMINATED | Results posted: 2014-06-23